The Korea Green Cross' stock price has skyrocketed in July.
Health Korea News, one of the Korean major online new papers released on 2 Agust its data analysis based on the domestic drugmaker's status of stocks in July.
According to this analysis, the Korea Green Cross has showed the highest stock price increase rate among the 20 superior ranking domestic drugmakers(based on sales) from 1 to 31 July.
On 31 July, its stock price has risen up 35.98% (130 thousand won) compared with the starting price(95.60 thousand won) of 1 July, thanks to a reflection of the premium value placed on an only domestic influenza vaccine maker.
On 1 July, the Korea Green Cross held the opening ceremony of its exclusive manufacturing plant for the vaccine in Hwasun, Jeonranam-do, and has been producing its new flu vaccine in earnest.
Choonwae Pharma's stock price and LG Life Science's stock price has risen up more than 10%, respectively.
Dong-A Pharmaceutical's stock price and Jeil Pharmaceutical's stock price have risen up more than 5%, respectively.
On the contrary, in case of Hanmi Pharmaceutical, Dong Wha Pharm and ILDONG Pharmaceutical, their stock prices have fallen down more than 10%. <헬스코리아뉴스>